Affiliation:
1. 2 Clinical Pharmacy Specialist, VA Tennessee Valley Healthcare System, Nashville, Tennessee
2. 3 Clinical Pharmacy Specialist, VA Tennessee Valley Healthcare System, Nashville, Tennessee
Abstract
Abstract
Introduction
At a Veterans Affairs Medical Center (VAMC), a clinical pharmacist practitioner (CPP) was added to an inpatient addiction triage team in August 2019 to provide education and recommendations regarding medications for alcohol use disorder (MAUD) and opioid use disorder (MOUD). Before the addition of the CPP, missed opportunities for MAUD and MOUD education and prescribing prior to discharge on non-psychiatric units were observed.
Methods
This was a single-center, single-site, retrospective, observational cohort study with a primary objective to compare initiation rates of MAUD/MOUD 12 months before and after the addition of the CPP to the addiction triage team. Secondary end points included 90-day medication possession ratio, 1- and 3-month emergency department visit rates, 1- and 3-month hospital readmission rates, and opioid education and naloxone distribution interventions for eligible patients with a diagnosis of opioid use disorder.
Results
Both statistically and clinically significant improvements in MAUD/MOUD initiation rates were found in the CPP intervention group compared with the historical control group (26.3% vs 4%, P < .0001). Although secondary end points within this review were not found to be statistically significant, improvements were seen in the CPP intervention group compared with the historical control group related to medication possession ratio, and emergency department and hospital readmission rates.
Discussion
This study highlights the potential utility of a CPP to an inpatient addiction triage team to improve MAUD/MOUD prescribing rates in appropriate patients prior to discharge. Overall, the introduction of a CPP to an inpatient addiction triage team was feasible, well received by interprofessional team members, and required limited additional resources.
Publisher
College of Psychiatric and Neurologic Pharmacists (CPNP)
Subject
Pharmacology (medical),Neurology (clinical),General Pharmacology, Toxicology and Pharmaceutics,Neuropsychology and Physiological Psychology
Reference17 articles.
1. Substance Abuse and Mental Health Services Administration [Internet]
National Survey of Drug Use and Health (NSDUH) releases;
2019
[cited 2021 Dec 20]. Available from: https://www.samhsa.gov/data/release/2019-national-survey-drug-use-and-health-nsduh-releases
2. National Institute on Drug Abuse [Internet].
Trends & statistics;
2017
[cited 2021 Dec 20]. Available from: https://www.drugabuse.gov/drug-topics/trends-statistics
3. Hannerz
H,
Borgå
P,
Borritz
M.
Life expectancies for individuals with psychiatric diagnoses.
Public Health.
2001;115(5):328-37.
DOI: 10.1038/sj.ph.1900785. PubMed PMID: 11593442.
4. Trowbridge
P,
Weinstein
ZM,
Kerensky
T,
Roy
P,
Regan
D,
Samet
JH,
et al.
Addiction consultation services – Linking hospitalized patients to outpatient addiction treatment.
J Subst Abuse Treat.
2017;79:
1-5.
DOI: 10.1016/j.jsat.2017.05.007. PubMed PMID: 28673521; PubMed Central PMCID: PMC6035788.
5. Ronan
MV,
Herzig
SJ.
Hospitalizations related to opioid abuse/dependence and associated serious infections increased sharply, 2002–12.
Health Aff (Milwood).
2016;35(5):832-37.
DOI: 10.1377/hlthaff.2015.1424. PubMed PMID: 27140989; PubMed Central PMCID: PMC5240777.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献